These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 73997)

  • 1. [Immunologic properties, aggregate content and half-life of various human i.v. gamma globulin preparations].
    Ring J; Duswald KH; Seifert J; Brendel W
    Langenbecks Arch Chir; 1976; Suppl():63-7. PubMed ID: 73997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prophylaxis and therapy with gamma globulin. General characterization and clinical use of gamma globulin preparations].
    Barandun S; Skvaril F; Morell A
    Schweiz Med Wochenschr; 1976 Apr; 106(16):533-42. PubMed ID: 62393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intravenous gamma globulin therapy in Bruton's antibody deficiency syndrome].
    Rossipal E
    Wien Med Wochenschr; 1978 Apr; 128(8):240-3. PubMed ID: 77587
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the elimination of fermentally disintegrated gamma globulin from the blood plasma].
    Mai K; Bläker F
    Z Immunitatsforsch Exp Klin Immunol; 1971 Aug; 142(2):173-82. PubMed ID: 4105637
    [No Abstract]   [Full Text] [Related]  

  • 5. [Structure and biological properties of immunoglobulins and gamma-globulin preparations. II. Properties of gamma-globulin preparations].
    Morell A; Skvaril F
    Schweiz Med Wochenschr; 1980 Jan; 110(3):80-5. PubMed ID: 6156490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical tolerance and catabolism of plasmin-treated gamma-globulin for intravenous application.
    Barandun S; Castel V; Makula MF; Morell A; Plan R; Skvaril F
    Vox Sang; 1975; 28(3):157-75. PubMed ID: 47211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of antitoxin and antibacterial activity of human preparations of normal immunoglobulin. I. Level of tetanus antitoxin in preparations of IMIG and IVIG].
    Zakrzewska A; Rymkiewicz D
    Przegl Epidemiol; 1995; 49(4):381-4. PubMed ID: 8868196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of antibody deficiency syndromes with subcutaneous infusion of gamma globulin.
    Roord JJ; van der Meer JW; Kuis W; van Furth R
    Birth Defects Orig Artic Ser; 1983; 19(3):217-21. PubMed ID: 6197108
    [No Abstract]   [Full Text] [Related]  

  • 9. [HTLV-III/LAV antibodies in gamma globulin preparations for intravenous use].
    Kaeser A
    Dtsch Med Wochenschr; 1986 Aug; 111(33):1263. PubMed ID: 2427300
    [No Abstract]   [Full Text] [Related]  

  • 10. Individualization of gamma globulin dosage in patients with humoral immunodeficiency.
    Schiff RI; Rudd C; Johnson R; Buckley RH
    Birth Defects Orig Artic Ser; 1983; 19(3):209-12. PubMed ID: 6197106
    [No Abstract]   [Full Text] [Related]  

  • 11. Conventional immunoglobulin therapy.
    Hitzig WH; Müntener U
    Birth Defects Orig Artic Ser; 1975; 11(1):339-42. PubMed ID: 50096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of non-enzymatic desamidation of gamma-globulin on its properties and biological activity].
    Lukash AI; Shepelev AP; Pushkina NV; Tsybul'skiĭ IE; Al'perovich DV
    Vopr Med Khim; 1985; 31(4):104-8. PubMed ID: 2413619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunoglobulins for intravenous administration: preparation and properties.
    Kistler P; Steiger G
    Prog Immunobiol Stand; 1970; 4():92-4. PubMed ID: 4098282
    [No Abstract]   [Full Text] [Related]  

  • 14. [Human plasma gamma globulin injectable by intravenous route].
    Steinbuch M; Blatrix C; Dormont J; Soulier JP
    Presse Med (1893); 1969 Apr; 77(17):635-7. PubMed ID: 4182082
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antigen-elimination technic. An in vivo method for studies of the human immune response against horse gamma globulin].
    Seifert J; Land W; Ring J; Lob G; Brendel W
    Fortschr Med; 1978 Apr; 96(13):695-7. PubMed ID: 75829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an intravenous gamma-globulin with Fc activities. II. Reconversion of S-sulfonated human gamma-globulin into the original gamma-globulin.
    Masuho Y; Tomibe K; Watanabe T; Fukumoto Y
    Vox Sang; 1977; 32(5):290-5. PubMed ID: 67714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Improved gamma globulin preparation and oral administration of secretory IgA].
    Matsumoto S; Watanabe T; Kobayashi K
    Nihon Rinsho; 1981 Apr; 39(4):1813-20. PubMed ID: 6171655
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental analysis of the complement-binding activity of gamma-globulin].
    Ternovoĭ AP; Skrigan ER
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Aug; (8):95-9. PubMed ID: 72470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of intravenous gamma globulins in pediatrics].
    Mattei M; Orsini A
    Ann Anesthesiol Fr; 1979; 20(6-7):549-52. PubMed ID: 95082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy with immunoglobulins with special regard to the problem of the efficacy of intravenously applied gammaglobulin in bacterial infections].
    Duswald KH; Ring J
    Klin Anasthesiol Intensivther; 1980; 21():207-23. PubMed ID: 6161270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.